DNA Funded Pricing Explained: All Plans, Costs & Fees (2026)

DNA Funded Pricing Overview

DNA Funded is an Australian prop firm offering four distinct challenge types designed to suit different trader profiles and timelines. The company, founded in 2024 and backed by ASIC-regulated DNA Markets broker, positions itself as an accessible entry point into proprietary trading with pricing starting at just $49 per month. Unlike many competitors charging upfront evaluation fees ranging from $200 to $500+, DNA Funded's straightforward monthly pricing model eliminates large initial capital barriers—a significant advantage for retail traders testing the prop firm ecosystem.

The platform operates on a refundable fee model: your challenge fee is returned upon your first profitable payout, effectively converting the entry cost into a deposit rather than a sunk cost. This structure is rare among prop firms and deserves consideration when comparing total cost of entry.

All DNA Funded Plans Compared

Plan Name	Monthly Cost	Duration	Best For
1 Phase (Single Helix)	$49/mo	No time limit	Patient traders, minimal pressure
2 Phase (Double Helix)	$49/mo	No time limit	Traders wanting two evaluation steps
Rapid (10-Day)	$99/mo	10 calendar days	Confident traders, quick path to funding
Instant Funding	$199/mo	Immediate access	Traders skipping evaluation entirely

1 Phase (Single Helix) – $49/month

DNA Funded's entry-level plan offers the lowest barrier to prop trading. For $49 per month, traders access a single evaluation phase with no time limits—a crucial differentiator in an industry obsessed with 30-day deadlines. This plan is ideal for traders who prefer a relaxed pace while building their track record.

• Access to 800+ CFD instruments (forex, indices, commodities, stocks, crypto)
• Raw spreads from 0.0 pips via TradeLocker platform
• Mobile app available for on-the-go trading
• Performance analytics and risk management tools included
• 80% profit split on successful trades
• Monthly fee refunded upon first payout

The unlimited timeline removes psychological pressure, making this attractive for traders testing strategies without rushing. However, the 1 Phase structure provides only a single evaluation window—there's no second chance if you hit stop-loss limits on your first try.

2 Phase (Double Helix) – $49/month

DNA Funded's most popular plan offers the same $49 monthly cost as the 1 Phase but adds a two-stage evaluation process. The Double Helix structure is identical in price but provides additional opportunity through a second evaluation phase.

• Two sequential evaluation phases (hence "Double Helix" branding)
• No time limits on either phase
• Same 800+ instrument access and 0.0 pip spreads as 1 Phase
• Same 80% profit split and fee refund on first payout
• Increased tolerance for drawdowns across two phases

The psychological advantage is significant: if you fail the first phase, you get another chance without paying additional fees. This makes the 2 Phase effectively better value than 1 Phase at the same price, explaining why this tier likely attracts most DNA Funded users.

Rapid (10-Day) – $99/month

For traders confident in their strategy and seeking fast-tracked funding, the Rapid challenge compresses evaluation into 10 calendar days. The 2x price increase reflects the accelerated timeline and higher perceived risk to the firm.

• $99 monthly fee for 10-day evaluation window
• Same 800+ CFD instruments except crypto is excluded
• Performance analytics and risk management tools included
• 80% profit split upon passing
• Fee refunded upon first payout
• Requires more active, decisive trading to generate measurable results

The crypto exclusion is a notable limitation compared to other tiers. The 10-day constraint also makes this unsuitable for day traders who work part-time or trade during specific market sessions.

Instant Funding – $199/month

DNA Funded's premium tier eliminates the challenge entirely. Traders pay $199 monthly for immediate funded account access, bypassing all evaluation requirements. This appeals to established traders with proven track records at other firms or traders prioritizing speed over cost savings.

• Immediate access to funded account (no evaluation phase)
• $199 monthly subscription model
• Full access to 800+ CFD instruments
• 80% profit split on all trades
• Suitable for traders with existing experience and confidence

At $199/month ($2,388 annually), this tier targets established traders willing to pay a premium for instant capital access rather than spending weeks in evaluation.

Free Plan / Free Trial

DNA Funded does not offer a free tier or trial account. All trading access requires a paid challenge subscription ($49 minimum monthly). This differs from some competitors offering free demo accounts or limited trial periods.

However, the monthly billing structure with no long-term commitments provides flexibility similar to a trial—traders can start with $49, evaluate the platform for a month, and cancel guilt-free if it doesn't fit their trading style. The fee refund upon first payout also softens the initial cost for successful traders.

For risk-averse traders, the 2 Phase Double Helix at $49/month is effectively the lowest-cost entry, offering two chances to prove profitability before the financial pressure becomes significant.

Hidden Costs and Fees

DNA Funded's pricing model is relatively transparent, but traders should consider these potential costs:

• Monthly subscription is mandatory: Unlike one-time evaluation fees, DNA Funded charges monthly. If you don't generate profits quickly, subscription costs accumulate ($49/month × 12 = $588/year on the basic plan).
• No explicit data feed costs mentioned: 800+ CFDs are included, but premium data or real-time feeds may carry additional costs (not disclosed in available pricing).
• TradeLocker platform fees: TradeLocker is the execution platform. While integration appears seamless, traders should verify no additional platform fees apply beyond the monthly subscription.
• Affiliate commission rates not public: If monetizing through affiliate recruiting, commission structures aren't disclosed, limiting passive income potential estimation.
• No withdrawal or account closure fees mentioned: However, standard broker withdrawal minimums likely apply (typically $100+).
• Potential losing streak costs: Unlike flat-fee evaluation models, long evaluation periods without profitability mean higher total subscription costs. A trader spending 6 months reaching profitability on the $49 plan pays $294 before earning their first split.

The absence of disclosed hidden costs is actually positive compared to competitors charging data feed surcharges or platform fees. DNA Funded's transparency here is a genuine advantage.

DNA Funded Pricing vs Competitors

DNA Funded positions itself as an affordable prop firm option. Here's how it compares:

Firm	Entry Price	Profit Split	Key Advantage
DNA Funded	$49/mo (lowest tier)	80%	ASIC-regulated, monthly billing, no time limits
Competitor A (Typical)	$99–$300 one-time	70–80%	Cheaper upfront, but nonrefundable
Competitor B (Premium)	$200–$500 one-time	75–85%	Larger accounts, higher stakes

The DNA Funded advantage: At $49/month, DNA Funded undercuts most competitors' one-time fees. A trader breaking even in 2 months pays $98 total—competitive with or cheaper than traditional prop firms. For comparison, a $200 one-time evaluation fee requires immediate capital commitment.

The DNA Funded trade-off: Monthly billing means recurring costs. A trader struggling to profit for 6 months pays $294, potentially exceeding what they'd pay in a $200 one-time fee to a competitor. Long-term profitability is essential to justify recurring costs.

For detailed competitor comparisons, see TradingToolsHub's full prop firm comparisons.

Is DNA Funded Worth the Price?

For most traders: Yes, the 2 Phase ($49/month) offers exceptional value.

The combination of ASIC regulation (rare in prop trading), unlimited evaluation time, two evaluation phases, and 80% profit splits at such a low monthly cost makes DNA Funded legitimately competitive. The fee refund upon profitability eliminates financial waste for successful traders.

Best-fit scenarios:

• Forex and CFD traders: 800+ instruments with raw 0.0 pip spreads target this demographic directly. If forex is your focus, DNA Funded's pricing is excellent.
• Patient traders: The no-time-limit structure rewards methodical traders who prefer consistency over speed. The $49/month entry fee removes pressure to force trades.
• Retail traders testing the prop firm model: Before committing $300+ to competitors, try DNA Funded's $49/month to validate the concept. If it doesn't work, your loss is capped at $49.
• Traders with established track records: The Instant Funding tier ($199/month) is a bargain for proven traders seeking quick capital access without weeks of evaluation.

Weak-fit scenarios:

• Crypto-focused traders: Crypto is excluded from the Rapid tier, and overall crypto offerings may be limited. Specialist crypto prop firms offer better support.
• Futures and options traders: These derivatives aren't available, making DNA Funded unsuitable for strategies relying on options or futures.
• Traders needing immediate funding: The evaluation phases require 1-2 successful trades. Only Instant Funding ($199/month) bypasses this, which isn't budget-friendly for cost-conscious traders.
• Traders with inconsistent income: Monthly recurring charges can strain budgets during losing months. One-time evaluation fees from competitors may suit irregular traders better.

When to upgrade within DNA Funded:

• From 1 Phase to 2 Phase: Not recommended—they cost the same, so start with 2 Phase for the extra safety net.
• To Rapid ($99/month): Only if you're confident in closing out profitably within 10 days. The 2x price increase justifies the speed only if time-to-funding matters more than cost.
• To Instant Funding ($199/month): Jump here only after proving profitability at lower tiers. Paying $199/month blind is expensive; prove your edge first at $49.

How to Save on DNA Funded

Public discounts: DNA Funded has not disclosed affiliate codes, seasonal promotions, or annual billing discounts in available materials. The published pricing appears fixed across all tiers.

Strategies to minimize cost:

• Start with 2 Phase ($49/month): This tier offers the best value—two evaluation attempts at the lowest price tier. No upgrade necessary if you're patient.
• Leverage the fee refund: The promise that fees return upon first payout means your first profitable trade effectively finances the next month. Plan trading activity around this.
• Avoid Rapid unless essential: At $99/month, the Rapid tier doubles your cost. Unless you specifically need 10-day evaluation, the unlimited 2 Phase is superior value.
• Test with $49 first: Before committing $199/month to Instant Funding, validate the platform and your strategy at the $49 tier. This one-month trial costs less than competitors' upfront evaluation fees.
• Monitor for promotional periods: As a young firm (founded 2024), DNA Funded may run launch promotions or seasonal discounts. Contact support to ask about upcoming offers.
• Consider affiliate recruiting: If you have trading networks, affiliate partnerships (commission rates undisclosed) could offset personal subscription costs, though this requires upfront networking investment.

For the latest promotions and detailed terms, visit the DNA Funded review page or contact their support team directly.

Final Verdict

DNA Funded's $49-per-month entry point, combined with ASIC regulation, unlimited evaluation time, and 80% profit splits, makes it a compelling option for retail traders entering prop trading. The 2 Phase tier especially offers genuine value—two evaluation chances at a cost that breaks even within 6-8 weeks of consistent trading.

The main risk: monthly recurring costs punish losing traders. However, this also incentivizes profitability and aligns trader and firm interests. For disciplined traders with edge, DNA Funded's pricing model is legitimately worth the cost.